Then in 2004 the EPO revoked the patent entirely.
最终，在2004年，欧洲专利局撤消了它的专利权。
Objective To find the detecting method of erythropoietin (EPO).
目的探索兴奋剂促红细胞生成素(EPO)的检测方法。
Research techniques on the preparation of EPO for injection use.
摸索制备注射用月见草油的小试工艺。
Erythropoietin (EPO) is widely used in clinical and basic studies.
红细胞生成素(EPO)在临床和基础研究中应用广泛。
Opponents were shocked when EPO upheld Monsanto's monopoly in 2003.
2003年当专利局坚持孟山都公司的垄断时，其对手感到震惊。
The EPO has only three official languages: English, French and German.
欧洲专利局的官方语言只有英语，法语及德语。
Nor may the Licensee pass on EPO data to third parties for such purposes.
被许可方也不得为了上述目的将E PO局数据交付给任何第三方。
EPO is not easy to be broken, so it is the best choice for the beginners.
促红细胞生成素是不容易被打破，因此它是初学者的最佳选择。
A copy of a EPO data carrier is not a Product according to this Agreement.
EPO数据载体副本不属于本协议项下的产品。
CCTV is like NBC on steroids... and growth hormone, and EPO, and albuterol.
CCTV就像是注射了类固醇、生长激素、EPO以及沙丁胺醇的NBC。
Lance Armstrong said, also that he only used a little bit of EPO previously.
兰斯·阿姆斯特朗表示，还说他之前只服用过一点点epo。
The EPO shall take all reasonable steps to avoid the inclusion of such non-conforming data.
欧洲专利局应当采取一切合理的措施，避免包含上述不符合要求的数据。
Erythropoietin (EPO) is a kind of endogenesis cell factor which was excreted by the kidney.
促红细胞生成素(EPO)是由肾脏分泌的内源性细胞因子。
The medium formulation have been studied to culture CHO cells producing erythropoietin(EPO).
研究了用中国仓鼠卵巢细胞（CHO）生产促红细胞生成素（EPO）的配方。
It was not affected cutting the nerves for EPO effect on erythropoietic response during hypoxia.
切除内脏大神经也不影响大鼠低氧时的红细胞生成e PO效应。
All data carriers will be supplied by the EPO to the Licensee in the format specified in Annex a.
所有数据载体将由欧洲专利局按照附件A指定的格式提供给被许可方。
Using EPO to treat radiotherapy and chemotherapy relevant anemia in NSCLS is the effective method.
应用促红细胞生成素(EPO)是治疗非小细胞型肺癌在放、化疗相关性贫血的有效方法。
Aim To study the effect of high C-reactive protein (CRP) on dose of erythropoietin (EPO) in hemodialysis patients.
目的研究高血清c反应蛋白(CRP)对血液透析患者促红细胞生成素(EPO)治疗效果的影响。
Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
前言： 目的：对红细胞生成素胶原蛋白双层微条的体外释放特性进行研究。
Like EPO, vascular endothelial growth factor spurs red-blood-cell formation and thus helps to supply tissues with oxygen.
跟EPO一样，血管内皮生长因子促使红细胞的形成从而帮助组织供血。
Renal anemia is mostly caused by insufficient EPO produced by kidney, which mainly required to be treated with external EPO.
肾性贫血主要是由于肾脏产生红细胞生成素(EPO)不足而引起，这类贫血主要靠补充外源性EPO进行治疗。
Studies have found that EPO receptor is widely distributed in a variety of non-hematopoietic tissue, including myocardial tissue.
研究发现EPO受体广泛分布于各种非造血组织，其中包括心脏组织。
Objective To explore erythropoietin(EPO) and ferrous sulfate therapy used to autohemotherapy(AHT) in the child cardiac operation.
目的探讨促红细胞生成素和硫酸亚铁治疗用于小儿心脏手术的术前自体献血（AHT）。
The existing evidence on the early use of EPO-A in the acute phase of trauma patients management consists of only 14 publications.
关于促红细胞生成素- A (EPO - A)应用于创伤患者治疗急性期的现存临床证据仅14篇已发表文献。
Conclusion Traditional medicine compound can improve anemia symptum of rat. Chronic adynamia could promote creation of EPO as well.
验证了中药复方可以改善慢性肾衰大鼠贫血状态，促进EPO生成。
Using epoetin (epo) has become the major treatment regimen for patients with cancer -, radiotherapy - and chemotherapy-related anemia.
应用促红细胞生成素(EPO)是目前治疗癌症及放、化疗相关性贫血的主要方法。
The Licensee is not permitted to copy an EPO data carrier using all data, data structure and software as sent to the Licensee by the EPO.
被许可方不得复制使用欧洲专利局送交被许可方的数据、数据结构和软件的欧洲专利局数据载体。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
Objective to investigate the effects of erythropoietin (EPO) gene transfer into skeleton muscle mediated by electroporation on renal anemia.
目的研究电脉冲介导的质粒红细胞生成素(EPO)基因肌肉转移效率以及对肾性贫血的治疗作用。
Objective to investigate the effects of erythropoietin (EPO) gene transfer into skeleton muscle mediated by electroporation on renal anemia.
目的研究电脉冲介导的质粒红细胞生成素(EPO)基因肌肉转移效率以及对肾性贫血的治疗作用。
应用推荐